omalizumab Flashcards
1
Q
main indication
A
add on in uncontrolled moderate/severe asthma
2
Q
mechanism of action
A
anti IgE - inhibits Th2 response and associated mediator release from basophil/mast cells
3
Q
administration
A
injection every 2-4 weeks
